search
Back to results

Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software

Primary Purpose

Myopia

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
control contact lens
Sponsored by
Coopervision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

6 Years - 35 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Are 6- 35 years of age
  2. Have had a self-reported visual exam in the last two years
  3. Have a contact lens refraction that fits within the available parameters of the study lenses
  4. Are able to read (or be read to), understand and sign the assent document if under 18 years old or are able to read, understand and sign the consent document if aged 18 or older (Children 6-years of age will not be asked to sign the assent form as per STERLING IRB.);
  5. Are under 18 years old and are accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document;
  6. Are willing to comply with the wear schedule (8 hour per night for every night, while sleeping)
  7. Are willing to comply with the visit schedule
  8. Have a refractive spherical component of their prescription between -0.50 and up to -6.00 diopters (inclusive) AND a refractive cylinder of no more than -1.75 diopters
  9. Have a refractive spherical component ≥ cylinder component
  10. Have a minimum visual acuity of +0.20 logMAR with each eye, when refracted at the Screening visit
  11. Have clear corneas and no active ocular disease
  12. Have no medication, medical condition, or ocular conditions that contraindicate contact wear OR are expected to affect lens comfort or vision across the 1-month study duration, in the opinion of the investigator
  13. Can be shown to have stable keratometry for at least the previous 1 month, if they have previously worn orthokeratology lenses.

Exclusion Criteria:

  1. Present at screening visit with the presence of ocular or systemic disease or reports the use medications which might interfere with orthokeratology contact lens wear, such as keratoconus, diabetes mellitus, steroid eye drops
  2. Have a post-treatment predicted flat K value ≤38.00D (e.g. Patient baseline flat keratometry value = 40.00, patient has 2.00D of myopic refractive error. 40.00-2.00= 38.00D)
  3. Have a known sensitivity to the diagnostic sodium fluorescein to be used in the study
  4. Are pregnant, planning a pregnancy or lactating
  5. Have amblyopia
  6. Have presbyopia or has dependence on spectacles for near work over the contact lenses
  7. Present at screening visit with the presence of clinically significant (grade >3; Efron scale) anterior segment abnormalities.
  8. Present at screening visit with slit lamp findings that would contraindicate orthokeratology contact lens wear such as:

    1. Pathological dry eye or associated findings
    2. Pterygium, pinguecula, or corneal scars within the visual axis
    3. Neovascularization > 0.75 mm from of the limbus
    4. Giant papillary conjunctivitis (GPC) worse than grade 1
    5. Anterior uveitis or iritis (past or present)
    6. Seborrheic eczema, Seborrheic conjunctivitis
    7. History of corneal ulcers or fungal infections
    8. Poor personal hygiene
    9. Aphakia

Sites / Locations

  • 4S Eyecare and OptometryRecruiting
  • Carillon Vision CareRecruiting
  • Bellaire Family EyeCareRecruiting
  • University Complutense of Madrid

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Control Lens

Arm Description

Outcomes

Primary Outcome Measures

Comfort
Comfort of lenses (VAS 0-10, 0,5 steps) after insertion, subjects will be graded on a scale from 0 to 10 with 0=painful, 10= can't feel the lenses
Comfort
Comfort of lenses (VAS 0-10, 0,5 steps) after insertion, subjects will be graded on a scale from 0 to 10 with 0=painful, 10= can't feel the lenses

Secondary Outcome Measures

Full Information

First Posted
May 19, 2022
Last Updated
September 22, 2022
Sponsor
Coopervision, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05389072
Brief Title
Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software
Official Title
Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
May 2023 (Anticipated)
Study Completion Date
May 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coopervision, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
As new orthokeratology fitting software emerges onto the market, it is of interest to assess their usefulness in guiding eye practitioners with lens fit. The goal of this study is to evaluate the comfort of Paragon orthokeratology lenses when they are fit using the new Procornea software.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
57 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Lens
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
control contact lens
Intervention Description
control CRT lens
Primary Outcome Measure Information:
Title
Comfort
Description
Comfort of lenses (VAS 0-10, 0,5 steps) after insertion, subjects will be graded on a scale from 0 to 10 with 0=painful, 10= can't feel the lenses
Time Frame
1 week
Title
Comfort
Description
Comfort of lenses (VAS 0-10, 0,5 steps) after insertion, subjects will be graded on a scale from 0 to 10 with 0=painful, 10= can't feel the lenses
Time Frame
1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Are 6- 35 years of age Have had a self-reported visual exam in the last two years Have a contact lens refraction that fits within the available parameters of the study lenses Are able to read (or be read to), understand and sign the assent document if under 18 years old or are able to read, understand and sign the consent document if aged 18 or older (Children 6-years of age will not be asked to sign the assent form as per STERLING IRB.); Are under 18 years old and are accompanied by a parent or legal guardian who is able to read, understand and sign the parental information and permission document; Are willing to comply with the wear schedule (8 hour per night for every night, while sleeping) Are willing to comply with the visit schedule Have a refractive spherical component of their prescription between -0.50 and up to -6.00 diopters (inclusive) AND a refractive cylinder of no more than -1.75 diopters Have a refractive spherical component ≥ cylinder component Have a minimum visual acuity of +0.20 logMAR with each eye, when refracted at the Screening visit Have clear corneas and no active ocular disease Have no medication, medical condition, or ocular conditions that contraindicate contact wear OR are expected to affect lens comfort or vision across the 1-month study duration, in the opinion of the investigator Can be shown to have stable keratometry for at least the previous 1 month, if they have previously worn orthokeratology lenses. Exclusion Criteria: Present at screening visit with the presence of ocular or systemic disease or reports the use medications which might interfere with orthokeratology contact lens wear, such as keratoconus, diabetes mellitus, steroid eye drops Have a post-treatment predicted flat K value ≤38.00D (e.g. Patient baseline flat keratometry value = 40.00, patient has 2.00D of myopic refractive error. 40.00-2.00= 38.00D) Have a known sensitivity to the diagnostic sodium fluorescein to be used in the study Are pregnant, planning a pregnancy or lactating Have amblyopia Have presbyopia or has dependence on spectacles for near work over the contact lenses Present at screening visit with the presence of clinically significant (grade >3; Efron scale) anterior segment abnormalities. Present at screening visit with slit lamp findings that would contraindicate orthokeratology contact lens wear such as: Pathological dry eye or associated findings Pterygium, pinguecula, or corneal scars within the visual axis Neovascularization > 0.75 mm from of the limbus Giant papillary conjunctivitis (GPC) worse than grade 1 Anterior uveitis or iritis (past or present) Seborrheic eczema, Seborrheic conjunctivitis History of corneal ulcers or fungal infections Poor personal hygiene Aphakia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jose Vega, OD
Phone
925-621-3761
Email
jvega2@coopervision.com
First Name & Middle Initial & Last Name or Official Title & Degree
Kelly Voltz, OD
Email
kvoltz@coopervisionsec.com
Facility Information:
Facility Name
4S Eyecare and Optometry
City
San Diego
State/Province
California
ZIP/Postal Code
92127
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Keith Wan
Phone
858-675-2020
Email
keithmwan@gmail.com
Facility Name
Carillon Vision Care
City
Glenview
State/Province
Illinois
ZIP/Postal Code
60025
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Andrew Neukirch
Phone
847-657-8787
Email
eyedocdrummer@gmail.com
Facility Name
Bellaire Family EyeCare
City
Bellaire
State/Province
Texas
ZIP/Postal Code
77401
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley Tucker, MD
Phone
713-664-8087
Facility Name
University Complutense of Madrid
City
Madrid
Country
Spain
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gonzalo Carracedo
Email
jgcarrac@ucm.es

12. IPD Sharing Statement

Learn more about this trial

Evaluation of The Comfort of Orthokeratology Lenses Fit Using A New Software

We'll reach out to this number within 24 hrs